On Thursday 12th February, we hosted the UK Pharmaceutical & MedTech Innovations Event in partnership with ISPE UK Affiliate, bringing together industry leaders, technical specialists and innovators from across the sector. The event provided a platform to explore the operational, regulatory and technical challenges shaping pharmaceutical and advanced therapy manufacturing today.
Simon Phillips delivered a comprehensive session on key aseptic processing considerations for viral vectors and live biologics. His presentation covered regulatory status, inspection readiness, and Nova’s latest work in gene therapies, offering valuable insight into the realities of bringing advanced therapies to market.
Laura Mason shared expert perspectives on nasal and pulmonary drug delivery. A notable takeaway was that there is still no commercially available multi-dose nasal powder device, underlining the technical and commercial complexities that remain in this area.
We also heard how the Women in Pharma initiative continues to support learning and development across the industry, fostering greater inclusion and professional growth throughout the sector.
David Phasey, Innovation Director at 3P, addressed three critical operational challenges facing manufacturers today:
Alongside our speaker line-up, we were so pleased to welcome some partners and suppliers in the exhibition space:
• Adelphi Healthcare Packaging
• Bürkert Fluid Control Systems UK & Ireland
• Conserva UK
• Industrial Technology Systems Ltd (ITS Ltd)
• IWT Pharma
• Pharmagraph
• S3 Process Limited
• YTRON Process Technology GmbH & Co. KG
We would like to thank all speakers, partners and attendees for contributing to such an engaging and forward-thinking event. The discussions, questions and conversations throughout the day reflected a shared commitment to advancing pharmaceutical and MedTech manufacturing.
Reflections from 3P innovation: